From January 1, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 660,000 shares, representing 0.12% for CNY 19.39 million under the buyback announced on October 28, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.18 CNY | -0.98% | -6.59% | -43.62% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.62% | 1.08B | |
+42.73% | 750B | |
+34.11% | 606B | |
-6.34% | 356B | |
+18.68% | 326B | |
+6.13% | 286B | |
+18.66% | 246B | |
-3.27% | 213B | |
+11.25% | 213B | |
+2.28% | 167B |
- Stock Market
- Equities
- 300363 Stock
- News Porton Pharma Solutions Ltd.
- Tranche Update on Porton Pharma Solutions Ltd.'s Equity Buyback Plan announced on October 28, 2023.